Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2535-2543
Published online before print November 12, 2007, doi: 10.1161/CIRCULATIONAHA.107.696583
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/22/2535    most recent
CIRCULATIONAHA.107.696583v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stroud, D. M.
Right arrow Articles by Morley, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stroud, D. M.
Right arrow Articles by Morley, G. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Related Collections
Right arrow Structure
Right arrow Arrythmias-basic studies
Right arrow Physiological and pathological control of gene expression

(Circulation. 2007;116:2535-2543.)
© 2007 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Abnormal Conduction and Morphology in the Atrioventricular Node of Mice With Atrioventricular Canal–Targeted Deletion of Alk3/Bmpr1a Receptor

Dina Myers Stroud, PhD; Vinciane Gaussin, PhD; John B.E. Burch, PhD; Cindy Yu, BS; Yuji Mishina, PhD; Michael D. Schneider, MD; Glenn I. Fishman, MD; Gregory E. Morley, PhD

From the Leon H. Charney Division of Cardiology (D.M.S., C.Y., G.I.F., G.E.M.), New York University School of Medicine, New York, NY; Department of Cell Biology and Molecular Medicine (V.G.), Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark; Cell and Developmental Biology Program (J.B.E.B.), Fox Chase Cancer Center, Philadelphia, Pa; National Institute of Environmental Health Sciences (Y.M.), Mason, Ohio; and Center for Cardiovascular Development (M.D.S.), Baylor College of Medicine, Houston, Tex.

Correspondence to Gregory E. Morley, New York University School of Medicine, Smilow Research Center, 8th Floor, 522 First Ave, New York, NY 10016. E-mail Gregory.Morley{at}nyumc.org

Received February 21, 2007; accepted August 31, 2007.

Background— The atrioventricular (AV) node is essential for the sequential excitation and optimized contraction of the adult multichambered heart; however, relatively little is known about its formation from the embryonic AV canal. A recent study demonstrated that signaling by Alk3, the type 1a receptor for bone morphogenetic proteins, in the myocardium of the AV canal was required for the development of both the AV valves and annulus fibrosus. To test the hypothesis that bone morphogenetic protein signaling also plays a role in AV node formation, we investigated conduction system function and AV node morphology in adult mice with conditional deletion of Alk3 in the AV canal.

Methods and Results— High-resolution optical mapping with correlative histological analysis of 28 mutant hearts revealed 4 basic phenotypic classes based on electrical activation patterns and volume-conducted ECGs. The frequency of AV node conduction and morphological abnormalities increased from no detectable anomalies (class I) to severe defects (class IV), which included the presence of bypass tracts, abnormal ventricular activation patterns, fibrosis of the AV node, and twin AV nodes.

Conclusion— The present findings demonstrate that bone morphogenetic protein signaling is required in the myocardium of the AV canal for proper AV junction development, including the AV node.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
R.H. Anderson, M.R. Boyett, H. Dobrzynski, J. Yanni, V.M. Christoffels, and A.F.M. Moorman
Letter by Anderson et al Regarding Article, "Abnormal Conduction and Morphology in the Atrioventricular Node of Mice With Atrioventricular Canal-Targeted Deletion of Alk3/Bmpr1a Receptor"
Circulation, August 5, 2008; 118(6): e105 - e105.
[Full Text] [PDF]


Home page
CirculationHome page
R. G. Gourdie and D. Sedmera
Letter by Gourdie and Sedmera Regarding Article, "Abnormal Conduction and Morphology in the Atrioventricular Node of Mice With Atrioventricular Canal-Targeted Deletion of Alk3/Bmpr1a Receptor"
Circulation, August 5, 2008; 118(6): e106 - e106.
[Full Text] [PDF]


Home page
CirculationHome page
D. M. Stroud, C. Yu, G. I. Fishman, G. E. Morley, V. Gaussin, J. B.E. Burch, Y. Mishina, and M. D. Schneider
Response to Letters Regarding Article, "Abnormal Conduction and Morphology in the Atrioventricular Node of Mice with Atrioventricular Canal Targeted Deletion of Alk3/Bmpr1a Receptor"
Circulation, August 5, 2008; 118(6): e107 - e107.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. L. Bakker, B. J. Boukens, M. T.M. Mommersteeg, J. F. Brons, V. Wakker, A. F.M. Moorman, and V. M. Christoffels
Transcription Factor Tbx3 Is Required for the Specification of the Atrioventricular Conduction System
Circ. Res., June 6, 2008; 102(11): 1340 - 1349.
[Abstract] [Full Text] [PDF]